Answers are grounded in this paper and cite their sources.
Type 2 diabetes remains one of the most common chronic diseases worldwide, and despite available treatment options, achieving optimal glycaemic control is still a challenge for many patients [1]. In recent years, the growing availability of smartphones and the development of continuous glucose monitoring (CGM) systems have created new opportunities to support daily self-management [6]. This narrative review aims to explore the role of smartphone-based glucose monitoring applications in the management of type 2 diabetes. The analysis is based on literature from PubMed and Google Scholar published between 2015 and 2026. The selected studies focused on the use of CGM systems integrated with mobile applications and their impact on clinical outcomes, patient adherence, and quality of life. The available evidence suggests that these technologies may improve glycaemic control, as reflected by reductions in HbA1c levels, increased time in range (TIR), and fewer episodes of hypo- and hyperglycaemia [14, 15]. In addition, they appear to support greater patient engagement and independence by providing real-time feedback and facilitating a better understanding of the relationship between lifestyle factors and glucose levels [6]. At the same time, several limitations need to be considered, including unequal access to technology and cost-related barriers [10]. Overall, smartphone-based CGM applications seem to be a valuable addition to standard diabetes care, although their effectiveness depends on proper implementation and long-term use.
No takes yet. Share an insight, caveat, or question.
Bajerski et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: